Characterizing high-risk SPOP mutations in prostate cancer: Insights from computational analysis and protein-ligand docking

Prostate cancer is a prevalent form of male malignancy in the urogenital tract and a significant cause of mortality globally. It can be asymptomatic in its earliest phases and often has a slow progression that only requires regular monitoring. According to GLOBOCAN 2018 estimates, there were 1276,106 new cases of prostate cancer recorded globally in 2018. The development and advancement of cancer depend on genetic mutations in specific genes, which disrupt crucial regulatory pathways. The speckle-type POZ protein ( SPOP ) is crucial in preventing tumor growth and is commonly altered in sporadic prostate cancers. Approximately 10 % of prostate cancers exhibit mutations in SPOP , making it the most prevalent type of non-synonymous mutation in primary prostate cancer. By utilizing various bioinformatics tools, we have identified the most harmful missense SNPs that could significantly impact the structure and function of SPOP . We employed SWISS MODEL for predicting the protein structures, and for structural analysis, we utilized the HOPE server. The molecular dynamics simulation was performed by GROMACS which revealed the notable structural stabilization and compactness the SPOP protein. MM-PBSA binding-energy analysis performed on 100 ns trajectories revealed a mean ΔG bind of -14.21± 3.02 kcal mol -1 , conforming the stable and energetically favorable interaction between Diosgenin an SPOP. Residue-level decomposition identified ASN62, ASP63, LYS64 and SER295 as key hotspots, reinforcing Diosgenin’s potential as a lead molecule for SPOP-associated prostate-cancer therapy. Protein-ligand docking was also conducted to study the interaction between the chosen ligand and the SPOP protein. In our study, we found 16 missense SNPs in the coding region of the SPOP gene. 3 SNPs (F102C, R221G, and L293H) were found to be particularly detrimental. This investigation into the study of damaging nsSNPs has the potential to be highly valuable in precision medicine, particularly when examining diseases related to SPOP .

Authors

Institutions

Publication Details

Journal
In Silico Research in Biomedicine
Published
2025-01-01
DOI
https://doi.org/10.1016/j.insi.2025.100114
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterizing high-risk SPOP mutations in prostate cancer: Insights from computational analysis and protein-ligand docking

Muhammad Khan, Maqsood Ahmad, Muhammad Aslam, Ali Umar et al.
In Silico Research in Biomedicine
Prostate Cancer Treatment and Research
article

Characterizing high-risk SPOP mutations in prostate cancer: Insights from computational analysis and protein-ligand docking

Muhammad Khan, Maqsood Ahmad, Muhammad Aslam, Ali Umar, Misbah Ullah Khan, Aman Ullah
article en

Abstract

Prostate cancer is a prevalent form of male malignancy in the urogenital tract and a significant cause of mortality globally. It can be asymptomatic in its earliest phases and often has a slow progression that only requires regular monitoring. According to GLOBOCAN 2018 estimates, there were 1276,106 new cases of prostate cancer recorded globally in 2018. The development and advancement of cancer depend on genetic mutations in specific genes, which disrupt crucial regulatory pathways. The speckle-type POZ protein ( SPOP ) is crucial in preventing tumor growth and is commonly altered in sporadic prostate cancers. Approximately 10 % of prostate cancers exhibit mutations in SPOP , making it the most prevalent type of non-synonymous mutation in primary prostate cancer. By utilizing various bioinformatics tools, we have identified the most harmful missense SNPs that could significantly impact the structure and function of SPOP . We employed SWISS MODEL for predicting the protein structures, and for structural analysis, we utilized the HOPE server. The molecular dynamics simulation was performed by GROMACS which revealed the notable structural stabilization and compactness the SPOP protein. MM-PBSA binding-energy analysis performed on 100 ns trajectories revealed a mean ΔG bind of -14.21± 3.02 kcal mol -1 , conforming the stable and energetically favorable interaction between Diosgenin an SPOP. Residue-level decomposition identified ASN62, ASP63, LYS64 and SER295 as key hotspots, reinforcing Diosgenin’s potential as a lead molecule for SPOP-associated prostate-cancer therapy. Protein-ligand docking was also conducted to study the interaction between the chosen ligand and the SPOP protein. In our study, we found 16 missense SNPs in the coding region of the SPOP gene. 3 SNPs (F102C, R221G, and L293H) were found to be particularly detrimental. This investigation into the study of damaging nsSNPs has the potential to be highly valuable in precision medicine, particularly when examining diseases related to SPOP .

In Silico Research in BiomedicineVol. 1
Islamia University of Bahawalpur (PK), University of Okara (PK), National College of Business Administration and Economics (PK)
Openalex Percentile: Top 55%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.